<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6563844\results\search\disease\results.xml">
  <result pre="comply with these terms. Abstract The high genetic variability of" exact="influenza" post="A viruses poses a continual challenge to seasonal and"/>
  <result pre="was observed. In addition to identifying dextromethorphan as a potential" exact="influenza" post="treatment option, our study illustrates the feasibility of a"/>
  <result pre="bioinformatics-driven rational approach for repurposing approved drugs against infectious diseases." exact="influenza" post="A virus drug repurposing antiviral (H1N1 and H3N2) activity"/>
  <result pre="glycoproteins. Based on the antigenic properties of these viral glycoproteins," exact="influenza" post="A viruses are classified into different subtypes. To date,"/>
  <result pre="(3, 4). With the exception of bat-associated subtypes (4), all" exact="influenza" post="A virus subtypes can be found in wild aquatic"/>
  <result pre="without causing severe disease (8). Even though the production of" exact="influenza" post="vaccines is well established, and the regulatory process allows"/>
  <result pre="play an important role in reducing disease severity during seasonal" exact="influenza" post="epidemics. Two classes of approved drugs against influenza A"/>
  <result pre="during seasonal influenza epidemics. Two classes of approved drugs against" exact="influenza" post="A virus infections have been available for years: adamantane-based"/>
  <result pre="of widespread use, and at this time, all circulating human" exact="influenza" post="A viruses are adamantane-resistant (12), and the number of"/>
  <result pre="inhibitor, has been licensed in Japan for the treatment of" exact="influenza" post="virus infections (14), and favipiravir, an inhibitor of the"/>
  <result pre="list of promising candidate proteins and pathways involved in the" exact="influenza" post="virus life cycle (18–21). Watanabe et al. previously described"/>
  <result pre="fetal calf serum (FCS), and 1% L-glutamine at 37°C. The" exact="influenza" post="A virus strains H1N1 A/Puerto Rico/8/34 (PR8, (23), H3N2"/>
  <result pre="the experiment was repeated including additional drug concentrations and different" exact="influenza" post="A strains. For the calculation of the 50% effective"/>
  <result pre="(mustela putorius furo, bred in-house) without antibodies against circulating seasonal" exact="influenza" post="A virus strains were treated orally every 8 h"/>
  <result pre="Influenza Virus Life Cycle Whole genome siRNA screens using different" exact="influenza" post="A virus strains and cell lines have yielded a"/>
  <result pre="a list of cellular proteins that are required in the" exact="influenza" post="virus life cycle (22). While it is in most"/>
  <result pre="that modulate their expression levels or activity may also inhibit" exact="influenza" post="virus. Therefore, we computationally searched for FDA-approved drugs annotated"/>
  <result pre="updated host factor network generated by a meta-analysis of available" exact="influenza" post="virus siRNA screen data sets (Figure 1). This bioinformatics"/>
  <result pre="(Table 1). Figure 1 Identification of candidate drugs. Network of" exact="influenza" post="host factors with drug targets highlighted. From the network"/>
  <result pre="DrugBank flat file version 3.0 (27). Table 1 Inhibition of" exact="influenza" post="A virus replication by licensed drugs with Drug ID"/>
  <result pre="Compounds Inhibit Influenza A Virus Replication To identify candidates with" exact="influenza" post="virus inhibitory activity, cells were pre-treated with the respective"/>
  <result pre="of the endosome, which may explain its inhibitory effect on" exact="influenza" post="A viruses (32). Naltrexone, a competitive opioid receptor agonist"/>
  <result pre="6-phosphogluconate dehydrogenase (PGD) in vitro (37), which is upregulated in" exact="influenza" post="A virus-infected cells (38). To determine whether the antiviral"/>
  <result pre="potential candidates extended to circulating seasonal H3N2 and pandemic H1N1" exact="influenza" post="strains, A/Victoria/36/2011 (H3N2), and A/Mexico/InDRE4487/2009 (H1N1pdm09) were included in"/>
  <result pre="cells were pretreated for 8 h and infected with the" exact="influenza" post="strains A/Puerto Rico/8/34 (PR8) (A), A/Mexico/InDRE4487/2009 (H1N1pdm09) (B), or"/>
  <result pre="index (SI) of the different compounds against H1N1 and H3N2" exact="influenza" post="A viruses. PR8 pH1N1 H3N2 CC50 (μM) EC50 (μM)"/>
  <result pre="different strains and even different virus families (16, 45). For" exact="influenza" post="virus, several whole genome siRNA screens have been published"/>
  <result pre="years (18–21), allowing the cross-matching of host proteins required for" exact="influenza" post="replication with known cellular drug targets. Using this approach,"/>
  <result pre="reduction of clinical signs, supporting its further consideration as an" exact="influenza" post="treatment option. High-throughput siRNA screens have opened a new"/>
  <result pre="for drug repurposing (46). This is of special relevance for" exact="infectious disease" post="targets with lesser market potential, as the development of"/>
  <result pre="subject of ongoing studies. Ferrets closely mimic the course of" exact="influenza" post="disease seen in humans (44, 60). Seasonal and pandemic"/>
  <result pre="disease seen in humans (44, 60). Seasonal and pandemic 2009" exact="influenza" post="viruses thus cause a mild to moderate disease of"/>
  <result pre="drugs are frequently used as over the counter remedies for" exact="influenza" post="and influenza-like respiratory infections, a more detailed evaluation of"/>
  <result pre="century. Emerg Infect Dis. (2006) 12:9–14. 10.3201/eid1201.05125416494710 2.OsterhausABrooksABrobergEMacIntyreRCapuaI. Why should" exact="influenza" post="be a public health priority. Vaccine. (2015) 33:7022–5. 10.1016/j.vaccine.2015.08.04926319062"/>
  <result pre="PA: Lippincott Williams &amp;amp; Wilkins (2013). p. 1151–85. 4.MehleA. Unusual" exact="influenza" post="A viruses in bats. Viruses. (2014) 6:3438–49. 10.3390/v609343825256392 5.NeumannGKawaokaYTransmission"/>
  <result pre="A viruses in bats. Viruses. (2014) 6:3438–49. 10.3390/v609343825256392 5.NeumannGKawaokaYTransmission of" exact="influenza" post="A viruses. Virology. (2015) 479–80:234–246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic"/>
  <result pre="influenza A viruses. Virology. (2015) 479–80:234–246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic" exact="avian influenza" post="as a zoonotic agent. Vet Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482"/>
  <result pre="A viruses. Virology. (2015) 479–80:234–246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic avian" exact="influenza" post="as a zoonotic agent. Vet Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482"/>
  <result pre="Vet Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482 7.PerdueMLSwayneDE. Public health risk from" exact="avian influenza" post="viruses. Avian Dis. (2005) 49:317–27. 10.1637/7390-060305R.116252482 8.WuHWangXXueMXueMWuCLuQet al.. Spatial"/>
  <result pre="Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482 7.PerdueMLSwayneDE. Public health risk from avian" exact="influenza" post="viruses. Avian Dis. (2005) 49:317–27. 10.1637/7390-060305R.116252482 8.WuHWangXXueMXueMWuCLuQet al.. Spatial"/>
  <result pre="al.. Spatial characteristics and the epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in five waves from 2013 to 2017"/>
  <result pre="Spatial characteristics and the epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in five waves from 2013 to 2017"/>
  <result pre="Zhejiang Province, China. PLoS One. (2017) 12:e0180763. 10.1371/journal.pone.018076328750032 9.NafzigerANPrattDS. Seasonal" exact="influenza" post="vaccination and technologies. J Clin Pharmacol. (2014) 54:719–31. 10.1002/jcph.29924691877"/>
  <result pre="6:187–98. 10.2147/IDR.S3660124277988 12.DeydeVMXuXBrightRAShawMSmithCBet al.. Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis."/>
  <result pre="10.1086/51893617570112 13.GubarevaLVBesselaarTGDanielsRSFryAGregoryVHuangWet al.. Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors, 2015–2016. Antiviral Res. (2017) 146:12–20."/>
  <result pre="10.1038/nrmicro303623728212 18.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The IFITM proteins mediate cellular resistance to" exact="influenza" post="A H1N1 virus, West Nile virus, and dengue virus."/>
  <result pre="al.. Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature. (2010) 463:818–22. 10.1038/nature0876020081832 20.KönigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human"/>
  <result pre="(2010) 463:818–22. 10.1038/nature0876020081832 20.KönigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human host factors required for" exact="influenza" post="virus replication. Nature. (2010) 463:813–7. 10.1038/nature0869920027183 21.ShapiraSDGat-ViksIShumBODricotAde GraceMMWuLet al.."/>
  <result pre="Cell. (2009) 139:1255–67. 10.1016/j.cell.2009.12.01820064372 22.WatanabeTWatanabeSKawaokaY. Cellular networks involved in the" exact="influenza" post="virus life cycle. Cell Host Microbe. (2010) 7:427–39. 10.1016/j.chom.2010.05.00820542247"/>
  <result pre="Cell Host Microbe. (2010) 7:427–39. 10.1016/j.chom.2010.05.00820542247 23.SvitekNRuddPAObojesKPilletSvon MesslingV. Severe seasonal" exact="influenza" post="in ferrets correlates with reduced interferon and increased IL-6"/>
  <result pre="28.SleemanKMishinVPDeydeVMFurutaYKlimovAIGubarevaLV. In vitro antiviral activity of favipiravir (T-705) against drug-resistant" exact="influenza" post="and 2009 A(H1N1) viruses. Antimicrobial Agents Chemother. (2010) 54:2517–24."/>
  <result pre="32.YamauchiYBoukariHBanerjeeISbalzariniIFHorvathPHeleniusA. Histone deacetylase 8 is required for centrosome cohesion and" exact="influenza" post="A virus entry. PLoS Pathog. (2011) 7:e1002316. 10.1371/journal.ppat.100231622046129 33.SuTPSuTCNakamuraYTsaiSY."/>
  <result pre="Enzyme Inhib Med Chem. (2010) 25:871–5. 10.3109/1475636090348958121054237 38.JankeRGenzelYWetzelMReichlU. Effect of" exact="influenza" post="virus infection on key metabolic enzyme activities in MDCK"/>
  <result pre="al.. Mast cell-induced lung injury in mice infected with H5N1" exact="influenza" post="virus. J Virol. (2012) 86:3347–56. 10.1128/JVI.06053-1122238293 40.LiuSL Li YHShiGYTangSHJiangSJHuangCWLiuPYet"/>
  <result pre="40.LiuSL Li YHShiGYTangSHJiangSJHuangCWLiuPYet al.. Dextromethorphan reduces oxidative stress and inhibits" exact="atherosclerosis" post="and neointima formation in mice. Cardiovasc Res. (2009) 82:161–9."/>
  <result pre="Effects of double combinations of amantadine, oseltamivir, and ribavirin on" exact="influenza" post="A (H5N1) virus infections in cell culture and in"/>
  <result pre="effects of dextromethorphan. PLoS ONE.9:e89985. 10.1371/journal.pone.008998524587167 43.BouvierNM. Animal models for" exact="influenza" post="virus transmission studies: a historical perspective. Curr Opin Virol."/>
  <result pre="10.1016/j.cell.2007.08.03617981125 58.OchiaiHKurokawaMNiwayamaS. Influence of trifluoperazine on the late stage of" exact="influenza" post="virus infection in MDCK cells. Antiviral Res. (1991) 15:149–60."/>
  <result pre="(1991) 15:149–60. 10.1016/0166-3542(91)90032-M1859203 59.FujiokaYTsudaMNanboAHattoriTSasakiJSasakiTet al.. A Ca(2+)-dependent signalling circuit regulates" exact="influenza" post="A virus internalization and infection. Nat Commun. (2013) 4:2763."/>
  <result pre="10.1038/ncomms376324434940 60.BelserJAKatzJMTumpeyTM. The ferret as a model organism to study" exact="influenza" post="A virus infection. Dis Model Mech. (2011) 4:575–9. 10.1242/dmm.00782321810904"/>
  <result pre="Characterization in vitro and in vivo of pandemic (H1N1) 2009" exact="influenza" post="viruses isolated from patients. J Virol. (2012) 86:9361–8. 10.1128/JVI.01214-1222718834"/>
 </snippets>
</snippetsTree>
